New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
07:19 EDTPFPTProofpoint upgraded to Outperform from Neutral at Wedbush
Wedbush upgraded Proofpoint to reflect a change in investment stance to focus on customer acquisition opportunities and solid growth following recent high profile security breaches. Price target raised to $45 from $30.
News For PFPT From The Last 14 Days
Check below for free stories on PFPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
08:57 EDTPFPTImperva should be bought after negative preannouncement, says Pacific Crest
After Impreva preannounced lower than expected Q1 revenue, Pacific Crest blamed the miss on a lack of sales execution and lengthening sales cycles. However, the firm is still upbeat on Imperva's outlook, as it expects demand for security products to increase. Pacific Crest reduced its price target on Imperva to $48 from $62. It recommends buying other IT security names, including Palo Alto (PANW) and Proofpoint (PFPT), on weakness in the wake of Imperva's guidance. The firm keeps Outperform ratings on all the stocks named.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use